These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12531358)

  • 41. A needle-free approach for topical immunization: antigen delivery via vesicular carrier system(s).
    Mahor S; Gupta PN; Rawat A; Vyas SP
    Curr Med Chem; 2007; 14(27):2898-910. PubMed ID: 18045135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationally designed strings of promiscuous CD4(+) T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines.
    Falugi F; Petracca R; Mariani M; Luzzi E; Mancianti S; Carinci V; Melli ML; Finco O; Wack A; Di Tommaso A; De Magistris MT; Costantino P; Del Giudice G; Abrignani S; Rappuoli R; Grandi G
    Eur J Immunol; 2001 Dec; 31(12):3816-24. PubMed ID: 11745403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Global use of Haemophilus influenzae type b conjugate vaccine.
    Ojo LR; O'Loughlin RE; Cohen AL; Loo JD; Edmond KM; Shetty SS; Bear AP; Privor-Dumm L; Griffiths UK; Hajjeh R
    Vaccine; 2010 Oct; 28(43):7117-22. PubMed ID: 20691265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Partridge S; Alvey J; Bernstein H; Blatter M; Bottenfield G; Guerrero J; Senders SD; Schuerman L; Cheuvart B; Holmes SJ
    Vaccine; 2007 Feb; 25(10):1806-13. PubMed ID: 17240493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions of conjugate vaccines and co-administered vaccines.
    Findlow H; Borrow R
    Hum Vaccin Immunother; 2016; 12(1):226-30. PubMed ID: 26619353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conjugate vaccines for preventing Haemophilus influenzae type b infections.
    Swingler G; Fransman D; Hussey G
    Cochrane Database Syst Rev; 2003; (4):CD001729. PubMed ID: 14583937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine.
    Tejedor JC; Omeñaca F; García-Sicilia J; Verdaguer J; Van Esso D; Esporrín C; Molina V; Muro M; Marés J; Enrubia M; Moraga F; García-Corbeira P; Dobbelaere K; Schuerman L;
    Pediatr Infect Dis J; 2004 Dec; 23(12):1109-15. PubMed ID: 15626947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The immunogenicity of oral poliomyelitis vaccine in a primary vaccination series at 2, 4 and 6 months given concurrently with Hib, hepatitis B and diphtheria, tetanus and whole-cell pertussis vaccines administered as three separate injections or as a combination pentavalent vaccine.
    Hogg K; Hogg G
    Vaccine; 2003 Jun; 21(21-22):2906-10. PubMed ID: 12798634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Martinón-Torres F; Boisnard F; Thomas S; Sadorge C; Borrow R;
    Vaccine; 2017 Jun; 35(30):3764-3772. PubMed ID: 28583305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch.
    Pearson FE; Muller DA; Roalfe L; Zancolli M; Goldblatt D; Kendall MA
    Vaccine; 2015 Nov; 33(48):6675-83. PubMed ID: 26518398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Materno-foetal transfer of H. influenzae and pneumococcal antibodies is influenced by prematurity and low birth weight: implications for conjugate vaccine trials.
    Okoko BJ; Wesumperuma LH; Hart AC
    Vaccine; 2001 Dec; 20(5-6):647-50. PubMed ID: 11738729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.
    Gatchalian S; Reyes M; Bernal N; Lefevre I; David MP; Han HH; Bock HL; Wolter J; Schuerman L
    Hum Vaccin; 2005; 1(5):198-203. PubMed ID: 17012860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RNA gene profile variation in peripheral blood mononuclear cells from rhesus macaques immunized with Hib conjugate vaccine, Hib capsular polysaccharide and TT carrier protein.
    Tang J; Zhang Y; Zhang X; Liao Y; Wang Y; Ouyang S; Che Y; Xu M; Pu J; Shen Q; He Z; Ye Q; Li Q
    BMC Immunol; 2018 Jan; 19(1):4. PubMed ID: 29368591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical relevance of lower Hib response in DTPa-based combination vaccines.
    Poolman J; Kaufhold A; De Grave D; Goldblatt D
    Vaccine; 2001 Mar; 19(17-19):2280-5. PubMed ID: 11257348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunisation against Haemophilus influenzae type b.
    Levy M; Menzies R
    Aust J Public Health; 1995 Feb; 19(1):108. PubMed ID: 7734585
    [No Abstract]   [Full Text] [Related]  

  • 59. Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity.
    Latz E; Franko J; Golenbock DT; Schreiber JR
    J Immunol; 2004 Feb; 172(4):2431-8. PubMed ID: 14764714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fully mobilizing host defense: building better vaccines.
    Raychaudhuri S; Rock KL
    Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.